Nuzenio

Mibc

Mibc news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 13 latest news signals 7 publisher sources 100/100 entity strength

Latest news

Explicating the Status of ctDNA MRD Testing in the MIBC Treatment Paradigm - CancerNetworkCancerNetwork · Thu, 06 Aug 2026 18:14:44 GMTNavigating Reimbursement and Timing in Postoperative ctDNA Testing for MIBC - CancerNetworkCancerNetwork · Thu, 06 Aug 2026 14:09:37 GMTNatera seeks Japan’s PMDA approval for Signatera test in MIBC - Medical Device NetworkMedical Device Network · Thu, 06 Aug 2026 10:17:11 GMTNatera Submits Signatera™ to Japan’s PMDA for Approval as a Companion Diagnostic in Muscle-Invasive Bladder Cancer - BioSpaceBioSpace · Thu, 06 Aug 2026 03:07:25 GMTPatient-Reported Outcomes with EV-Pembrolizumab vs Cystectomy Alone in MIBC - Peter O'Donnell - UroTodayUroToday · Thu, 06 Aug 2026 01:03:19 GMTNCCN Guidelines: Navigating ctDNA MRD Testing in Evolving MIBC Paradigms - CancerNetworkCancerNetwork · Wed, 05 Aug 2026 18:04:30 GMTSignatera Is Submitted to Japan's PMDA for Companion Diagnostic Approval in MIBC - OncLiveOncLive · Wed, 05 Aug 2026 15:09:02 GMTThe MIBC Referral Gap: Why Half of Patients Miss Perioperative Therapy - Urology TimesUrology Times · Fri, 31 Jul 2026 16:06:20 GMT

Timeline

Thu, 06 Aug 2026 18:14:44 GMTExplicating the Status of ctDNA MRD Testing in the MIBC Treatment Paradigm - CancerNetwork
Thu, 06 Aug 2026 14:09:37 GMTNavigating Reimbursement and Timing in Postoperative ctDNA Testing for MIBC - CancerNetwork
Thu, 06 Aug 2026 10:17:11 GMTNatera seeks Japan’s PMDA approval for Signatera test in MIBC - Medical Device Network
Thu, 06 Aug 2026 03:07:25 GMTNatera Submits Signatera™ to Japan’s PMDA for Approval as a Companion Diagnostic in Muscle-Invasive Bladder Cancer - BioSpace
Thu, 06 Aug 2026 01:03:19 GMTPatient-Reported Outcomes with EV-Pembrolizumab vs Cystectomy Alone in MIBC - Peter O'Donnell - UroToday
Wed, 05 Aug 2026 18:04:30 GMTNCCN Guidelines: Navigating ctDNA MRD Testing in Evolving MIBC Paradigms - CancerNetwork

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Mibc.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

7 distinct publisher/source names are currently connected to this entity page.